BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 1378904)

  • 1. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta.
    Johns TG; Mackay IR; Callister KA; Hertzog PJ; Devenish RJ; Linnane AW
    J Natl Cancer Inst; 1992 Aug; 84(15):1185-90. PubMed ID: 1378904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
    Hertzog PJ; Johns TG; Callister KA; Dinatale A; Linnane AW
    Biochem Int; 1990 Dec; 22(6):1095-102. PubMed ID: 2151021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
    Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
    J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro comparative study of the antitumor effects of human interferon-alpha, beta and gamma on the growth and invasive potential of human melanoma cells.
    Horikoshi T; Fukuzawa K; Hanada N; Ezoe K; Eguchi H; Hamaoka S; Tsujiya H; Tsukamoto T
    J Dermatol; 1995 Sep; 22(9):631-6. PubMed ID: 8537547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral-acting benzodiazepines inhibit the growth of human melanoma cells and potentiate the antiproliferative activity of recombinant human interferons.
    Solowey WE; Pestka S; Spector S; Fryer RI; Fisher PB
    J Interferon Res; 1990 Jun; 10(3):269-80. PubMed ID: 1696606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay.
    Higashihara J; Saito T; Berens ME; Welander CE
    Cancer Chemother Pharmacol; 1988; 22(3):215-22. PubMed ID: 3136942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
    Losinno C; Wines BD; Johns TG; Mackay IR
    Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations.
    Dick RS; Hubbell HR
    J Neurooncol; 1987; 5(4):331-8. PubMed ID: 2450181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro sensitivity of human melanoma cells to chemotherapeutic agents and interferons.
    Schadendorf D; Jurgovsky K; Worm M; Czarnetzki BM
    Melanoma Res; 1994 Aug; 4(4):243-9. PubMed ID: 7524835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of alpha-, beta- and gamma-interferon on the growth of breast cancer cell lines.
    Coradini D; Biffi A; Pirronello E; Di Fronzo G
    Anticancer Res; 1994; 14(5A):1779-84. PubMed ID: 7531412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
    Gomi K; Akinaga S; Oka T; Morimoto M
    Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors.
    Wagner TC; Velichko S; Chesney SK; Biroc S; Harde D; Vogel D; Croze E
    Int J Cancer; 2004 Aug; 111(1):32-42. PubMed ID: 15185340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of growth suppression and modulation of the antigenic phenotype in human melanoma cells by the combination of recombinant human fibroblast and immune interferons.
    Graham GM; Guarini L; Moulton TA; Datta S; Ferrone S; Giacomini P; Kerbel RS; Fisher PB
    Cancer Immunol Immunother; 1991; 32(6):382-90. PubMed ID: 1672507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth inhibition of melanoma cells by interferons in vitro. Similar antiproliferative effects of 100-1000 times lower concentrations of nIFN-beta in comparison with rIFN-alpha-2a].
    Zouboulis C; Garbe C; Orfanos CE
    Hautarzt; 1989 Feb; 40(2):65-9. PubMed ID: 2714987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA.
    Hubbell HR; Liu RS; Maxwell BL
    Cancer Res; 1984 Aug; 44(8):3252-7. PubMed ID: 6204744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.
    Chawla-Sarkar M; Leaman DW; Borden EC
    Clin Cancer Res; 2001 Jun; 7(6):1821-31. PubMed ID: 11410525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
    Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
    J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro.
    Lindner DJ; Borden EC
    J Interferon Cytokine Res; 1997 Nov; 17(11):681-93. PubMed ID: 9402106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity to extrinsically supplied interferon and the endogenous expression of interferon in melanoma cell lines.
    Hanson C; Köpf I; Weijdegård B; Weimarck A; Stierner U
    Melanoma Res; 1999 Oct; 9(5):451-6. PubMed ID: 10596911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
    Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
    Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.